- Home
- WST vs LI Comparison
WST vs LI Comparison
Compare WST & LI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WST
- LI
- Stock Information
- Founded
- WST 1923
- LI 2015
- Country
- WST United States
- LI China
- Employees
- WST N/A
- LI N/A
- Industry
- WST Medical/Dental Instruments
- LI Auto Manufacturing
- Sector
- WST Health Care
- LI Consumer Discretionary
- Exchange
- WST Nasdaq
- LI Nasdaq
- Market Cap
- WST 15.6B
- LI 28.5B
- IPO Year
- WST N/A
- LI 2020
- Fundamental
- Price
- WST $221.34
- LI $26.14
- Analyst Decision
- WST Buy
- LI Buy
- Analyst Count
- WST 7
- LI 5
- Target Price
- WST $331.67
- LI $31.72
- AVG Volume (30 Days)
- WST 693.0K
- LI 4.1M
- Earning Date
- WST 07-24-2025
- LI 05-29-2025
- Dividend Yield
- WST 0.38%
- LI N/A
- EPS Growth
- WST N/A
- LI N/A
- EPS
- WST 6.37
- LI 1.05
- Revenue
- WST $2,895,800,000.00
- LI $19,948,060,367.00
- Revenue This Year
- WST $3.38
- LI $23.04
- Revenue Next Year
- WST $5.85
- LI $27.91
- P/E Ratio
- WST $34.66
- LI $24.85
- Revenue Growth
- WST N/A
- LI 10.75
- 52 Week Low
- WST $187.43
- LI $17.44
- 52 Week High
- WST $352.33
- LI $33.12
- Technical
- Relative Strength Index (RSI)
- WST 54.22
- LI 40.13
- Support Level
- WST $215.67
- LI $26.80
- Resistance Level
- WST $226.80
- LI $28.60
- Average True Range (ATR)
- WST 5.24
- LI 0.58
- MACD
- WST -0.13
- LI -0.25
- Stochastic Oscillator
- WST 58.92
- LI 13.65
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
About LI Li Auto Inc.
Li Auto is a leading Chinese NEV manufacturer that designs, develops, manufactures, and sells premium smart NEVs. The company started volume production of its first model Li One in November 2019. The model is a six-seater, large, premium plug-in electric SUV equipped with a range extension system and advanced smart vehicle solutions. It sold over 500,000 NEVs in 2024, accounting for about 4% of China's passenger new energy vehicle market. Beyond Li One, the company expands its product line, including both BEVs and PHEVs, to target a broader consumer base.